202 related articles for article (PubMed ID: 23466358)
1. Complete response of endemic Kaposi sarcoma lesions with high-dose-rate brachytherapy: treatment method, results, and toxicity using skin surface applicators.
Kasper ME; Richter S; Warren N; Benda R; Shang C; Ouhib Z
Brachytherapy; 2013; 12(5):495-9. PubMed ID: 23466358
[TBL] [Abstract][Full Text] [Related]
2. Custom mold applicator high-dose-rate brachytherapy for nonmelanoma skin cancer-An analysis of 273 lesions.
Olek D; El-Ghamry MN; Deb N; Thawani N; Shaver C; Mutyala S
Brachytherapy; 2018; 17(3):601-608. PubMed ID: 29398593
[TBL] [Abstract][Full Text] [Related]
3. HDR brachytherapy for superficial non-melanoma skin cancers.
Gauden R; Pracy M; Avery AM; Hodgetts I; Gauden S
J Med Imaging Radiat Oncol; 2013 Apr; 57(2):212-7. PubMed ID: 23551783
[TBL] [Abstract][Full Text] [Related]
4. Hypofractionated high-dose-rate plesiotherapy in nonmelanoma skin cancer treatment.
Arenas M; Arguís M; Díez-Presa L; Henríquez I; Murcia-Mejía M; Gascón M; Gómez D; Lafuerza A; Mur E; Azón A; Rovirosa À; Sabater S
Brachytherapy; 2015; 14(6):859-65. PubMed ID: 26489922
[TBL] [Abstract][Full Text] [Related]
5. Surface applicators for high dose rate brachytherapy in AIDS-related Kaposi's sarcoma.
Evans MD; Yassa M; Podgorsak EB; Roman TN; Schreiner LJ; Souhami L
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):769-74. PubMed ID: 9336161
[TBL] [Abstract][Full Text] [Related]
6. High-dose-rate brachytherapy in the treatment of skin Kaposi sarcoma.
Ruiz MÁG; Rivero JQ; García JLM; Rodríguez JJC; Kavadoy YR; Carmona MFR; Campos AC; Urra FG; Muñoz MCC; Herrero AR; Manzano PA
J Contemp Brachytherapy; 2017 Dec; 9(6):561-565. PubMed ID: 29441101
[TBL] [Abstract][Full Text] [Related]
7. Clinical and cosmetic outcomes in patients treated with high-dose-rate electronic brachytherapy for nonmelanoma skin cancer.
Paravati AJ; Hawkins PG; Martin AN; Mansy G; Rahn DA; Advani SJ; Hoisak J; Dragojevic I; Martin PJ; Miller CJ; Sanghvi P
Pract Radiat Oncol; 2015; 5(6):e659-64. PubMed ID: 26432680
[TBL] [Abstract][Full Text] [Related]
8. High dose rate brachytherapy with customized applicators for malignant facial skin lesions.
Jumeau R; Renard-Oldrini S; Courrech F; Buchheit I; Oldrini G; Vogin G; Peiffert D
Cancer Radiother; 2016 Jul; 20(5):341-6. PubMed ID: 27321412
[TBL] [Abstract][Full Text] [Related]
9. Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custom-made surface molds.
Guix B; Finestres F; Tello J; Palma C; Martinez A; Guix J; Guix R
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):95-102. PubMed ID: 10758310
[TBL] [Abstract][Full Text] [Related]
10. Nonmelanoma skin cancer treated with electronic brachytherapy: results at 1 year.
Bhatnagar A
Brachytherapy; 2013; 12(2):134-40. PubMed ID: 23312675
[TBL] [Abstract][Full Text] [Related]
11. Tumor control and cosmetic outcome of weekly iridium-192 high-dose-rate brachytherapy for nonmelanoma skin cancers in the elderly.
Roberson J; Patel R; Slutsky JB; Ryu S; Xu Z; Valentine E
Brachytherapy; 2021; 20(4):818-827. PubMed ID: 33789824
[TBL] [Abstract][Full Text] [Related]
12. Endoluminal high-dose-rate brachytherapy for early stage and recurrent esophageal cancer in medically inoperable patients.
Folkert MR; Cohen GN; Wu AJ; Gerdes H; Schattner MA; Markowitz AJ; Ludwig E; Ilson DH; Bains MS; Zelefsky MJ; Goodman KA
Brachytherapy; 2013; 12(5):463-70. PubMed ID: 23434221
[TBL] [Abstract][Full Text] [Related]
13. [The indications for and results of HDR afterloading therapy in diseases of the skin and mucosa with standardized surface applicators (the Leipzig applicator)].
Köhler-Brock A; Prager W; Pohlmann S; Kunze S
Strahlenther Onkol; 1999 Apr; 175(4):170-4. PubMed ID: 10230459
[TBL] [Abstract][Full Text] [Related]
14. A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.
Vargas C; Ghilezan M; Hollander M; Gustafson G; Korman H; Gonzalez J; Martinez A
J Urol; 2005 Sep; 174(3):882-7. PubMed ID: 16093980
[TBL] [Abstract][Full Text] [Related]
15. Treatment of keloids by high-dose-rate brachytherapy: A seven-year study.
Guix B; Henríquez I; Andrés A; Finestres F; Tello JI; Martínez A
Int J Radiat Oncol Biol Phys; 2001 May; 50(1):167-72. PubMed ID: 11316560
[TBL] [Abstract][Full Text] [Related]
16. High-dose-rate brachytherapy with or without intensity modulated radiation therapy as salvage treatment for an isolated, gross local recurrence of prostate cancer post-prostatectomy.
Strom TJ; Wilder RB; Fernandez DC; Mellon EA; Saini AS; Hunt DC; Biagioli MC
Brachytherapy; 2014; 13(2):123-7. PubMed ID: 24269146
[TBL] [Abstract][Full Text] [Related]
17. High dose-rate versus low dose-rate brachytherapy for lip cancer.
Ghadjar P; Bojaxhiu B; Simcock M; Terribilini D; Isaak B; Gut P; Wolfensberger P; Brömme JO; Geretschläger A; Behrensmeier F; Pica A; Aebersold DM
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1205-12. PubMed ID: 22099044
[TBL] [Abstract][Full Text] [Related]
18. Comparison of
Safigholi H; Meigooni AS; Song WY
Med Phys; 2017 Sep; 44(9):4426-4436. PubMed ID: 28494095
[TBL] [Abstract][Full Text] [Related]
19. Radiation therapy for the treatment of skin Kaposi sarcoma.
Tsao MN; Sinclair E; Assaad D; Fialkov J; Antonyshyn O; Barnes E
Ann Palliat Med; 2016 Oct; 5(4):298-302. PubMed ID: 27701876
[TBL] [Abstract][Full Text] [Related]
20. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
